Related Experiment Video
Updated: Jun 15, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Relapsing polychondritis: An autoimmune disease with many faces
Tobias Lahmer1, Matthias Treiber, Alexander von Werder
1Department of Nephrology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Germany. Tobias.Lahmer@lrz.tu-muenchen.de
Autoimmunity Reviews
|March 11, 2010
Summary
Relapsing polychondritis (RPC) is a rare immune-mediated condition causing cartilage inflammation. This review details its clinical signs, diagnosis, and varied treatment options due to limited clinical trials.
Area of Science:
- Rheumatology
- Immunology
- Rare Diseases
Background:
- Relapsing polychondritis (RPC) is a rare immune-mediated disorder characterized by inflammation of cartilaginous tissues.
- Affected areas commonly include the ears, nose, joints, and respiratory tract.
- RPC is associated with systemic vasculitis or myelodysplastic syndrome in approximately 30% of cases.
Purpose of the Study:
- To provide a comprehensive overview of relapsing polychondritis.
- To detail the clinical manifestations and diagnostic approaches for RPC.
- To review current and emerging therapeutic strategies for managing RPC.
Main Methods:
- Literature review of clinical manifestations, diagnosis, and treatment of relapsing polychondritis.
- Analysis of case reports and existing studies on RPC management.
- Examination of the efficacy of various immunosuppressive agents and novel therapies.
Main Results:
- RPC presents with diverse clinical symptoms affecting multiple cartilaginous structures.
- Diagnosis relies on clinical findings and exclusion of other conditions, as specific biomarkers are lacking.
- Treatment strategies are often empirical, utilizing immunosuppressants like cyclophosphamide, azathioprine, and TNF-alpha antagonists with variable success.
Conclusions:
- Relapsing polychondritis requires a multidisciplinary approach for effective management.
- Further research and clinical trials are needed to establish evidence-based treatment guidelines.
- Early diagnosis and tailored therapy are crucial for improving outcomes in RPC patients.
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...